Saad B. Ahmed

Broomfield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc.

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc.

Journal: Rheumatology (Oxford, England)

Published: February 23, 2026

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.

Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell-activating factor levels and a B cell subset-wide reduction of BAFF receptor expression in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: February 23, 2026

Can we use patient-reported outcomes for remote monitoring in SSc?

Can we use patient-reported outcomes for remote monitoring in SSc?

Journal: Rheumatology (Oxford, England)

Published: January 22, 2026

Current pharmacological management, treatment challenges, and potential future treatment options for fibromyalgia syndrome.

Current pharmacological management, treatment challenges, and potential future treatment options for fibromyalgia syndrome.

Journal: Expert opinion on pharmacotherapy

Published: December 14, 2025

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.

Journal: Rheumatology advances in practice

Published: June 26, 2025

Exploring the optimal follow-up for systemic sclerosis patients: study protocol for a Dutch multicenter randomized controlled trial.

Exploring the optimal follow-up for systemic sclerosis patients: study protocol for a Dutch multicenter randomized controlled trial.

Journal: Trials

Published: June 04, 2025

Evolution of the axial spondyloarthritis disease activity score and uptake in clinical practice.

Evolution of the axial spondyloarthritis disease activity score and uptake in clinical practice.

Journal: Current opinion in rheumatology

Published: May 21, 2025

Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis.

Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis.

Journal: RMD open

Published: April 11, 2025

Jeopardy to life and limb-using immunogenotyping to characterize inflammatory phenotypes: a case report.

Jeopardy to life and limb-using immunogenotyping to characterize inflammatory phenotypes: a case report.

Journal: Rheumatology advances in practice

Published: February 12, 2025

An atypical case of rheumatoid arthritis serositis.

An atypical case of rheumatoid arthritis serositis.

Journal: Rheumatology (Oxford, England)

Published: November 26, 2024

Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosis.

Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosis.

Journal: RMD open

Published: November 05, 2024

Evaluating the Effectiveness of an Online Targeted Education Programme on Vascular Surgery Aimed at Early Postgraduate Doctors.

Evaluating the Effectiveness of an Online Targeted Education Programme on Vascular Surgery Aimed at Early Postgraduate Doctors.

Journal: Cureus

Published: September 29, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026